VILEPSIA 200 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the Patient

Vilepsia 50mg film-coated tablets EFG

Vilepsia 100mg film-coated tablets EFG

Vilepsia 150mg film-coated tablets EFG

Vilepsia 200mg film-coated tablets EFG

lacosamide

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

• Keep this package leaflet, as you may need to read it again.
• If you have any doubts, consult your doctor or pharmacist.
• This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

1. What is Vilepsia and what is it used for
2. What you need to know before taking Vilepsia
3. How to take Vilepsia
4. Possible side effects
5. Storage of Vilepsia
6. Package contents and additional information

1. What is Vilepsia and what is it used for

What isVilepsia

Vilepsia contains lacosamide, which belongs to a group of medications called "antiepileptic medications". These medications are used to treat epilepsy.

• You have been prescribed this medication to reduce the number of seizures you experience.

What isVilepsiaused for

• Lacosamide is used:

• alone and with other antiepileptics in adults, adolescents, and children from 2 years of age to treat a certain type of epilepsy characterized by the onset of partial seizures with or without secondary generalization. In this type of epilepsy, seizures affect only one side of the brain. However, they can then spread to larger areas on both sides of the brain;
• with other antiepileptics in adults, adolescents, and children from 4 years of age to treat primary generalized tonic-clonic seizures (major seizures, with loss of consciousness) in patients with idiopathic generalized epilepsy (a type of epilepsy believed to have a genetic origin).

2. What you need to know before taking Vilepsia

Do not takeVilepsia

• if you are allergic to lacosamide or any of the other components of this medication (listed in section 6). If you are not sure if you are allergic, consult your doctor.
• if you have a heart rhythm problem called second or third degree AV block.

Do not take lacosamide if any of the above applies to you. If you are not sure, consult your doctor or pharmacist before taking this medication.

Warnings and precautions

Consult your doctor before starting to use lacosamide if:

• you have thoughts of self-harm or suicide. A small number of people taking antiepileptics such as lacosamide have had thoughts of self-harm or suicide. If you ever have these thoughts, contact your doctor immediately.
• you have a heart problem that affects your heartbeat and your pulse is often particularly slow, fast, or irregular (such as AV block, atrial fibrillation, and atrial flutter).
• you have severe heart disease such as heart failure or have had a heart attack.
• you often feel dizzy or fall. Lacosamide may cause dizziness, which could increase the risk of accidental injuries or falls. This means you should be careful until you are used to the effects of this medication.

If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking lacosamide.

If you are taking lacosamide, consult your doctor if you experience a new type of seizure or worsening of existing seizures.

If you are taking lacosamide and experience symptoms of abnormal heartbeat (such as slow, fast, or irregular heartbeat, palpitations, shortness of breath, dizziness, fainting), consult your doctor immediately (see section 4).

Children

Lacosamide is not recommended in children under 2 years of age with epilepsy characterized by the onset of partial seizures or in children under 4 years of age with primary generalized tonic-clonic seizures. This is because it is not yet known if it is effective and safe for children in this age group.

Other medications andVilepsia

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

In particular, tell your doctor or pharmacist if you are taking any of the following medications that affect the heart, as lacosamide may also affect the heart:

• medications for heart problems.
• medications that may increase the "PR interval" in a heart test (ECG or electrocardiogram) such as epilepsy or pain medications called carbamazepine, lamotrigine, or pregabalin.
• medications used to treat certain types of arrhythmia or heart failure. If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist before taking lacosamide.

Also, inform your doctor or pharmacist if you are taking any of the following medications, as they may also increase or decrease the effect of lacosamide in your body:

• medications for fungal infections such as fluconazole, itraconazole, or ketoconazole.
• HIV medications such as ritonavir.
• medications for bacterial infections such as clarithromycin or rifampicin.
• a herbal remedy used to treat mild anxiety and depression called St. John's Wort.

If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist before taking lacosamide.

TakingVilepsiawith alcohol

As a precaution, do not take lacosamide with alcohol.

Pregnancy and breastfeeding

Women of childbearing age should discuss the use of contraceptives with their doctor.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Lacosamide is not recommended if you are pregnant, as its effects on pregnancy and the fetus are not known.

It is not recommended to breastfeed while taking lacosamide, as lacosamide passes into breast milk.

Seek immediate advice from your doctor if you are pregnant or plan to become pregnant. They will help you decide whether to take lacosamide or not.

Do not stop treatment without talking to your doctor first, as this could increase seizures (epilepsy). Worsening of your condition may also harm the fetus.

Driving and using machines

You should not drive, ride a bicycle, or use any tool or machine until you know if this medication affects you. The reason is that lacosamide may cause dizziness or blurred vision.

3. How to take Vilepsia

Follow the instructions for administering this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Other presentations of this medication may be more suitable for children; consult your doctor or pharmacist.

TakingVilepsia

• Take lacosamide twice a day, with an interval of approximately 12 hours.
• Try to take it more or less at the same time every day.
• Take the lacosamide tablet with a glass of water.
• You can take lacosamide with meals or separately.

Normally, you will start taking a low dose every day, and your doctor will gradually increase the dose over several weeks. When you reach the dose that works well for you, called the "maintenance dose", you will take the same amount every day. Lacosamide is used as long-term treatment. You will need to continue taking lacosamide until your doctor tells you to stop.

How much to take

The following are the usual recommended doses of lacosamide for different age and weight groups. Your doctor may prescribe a different dose if you have kidney or liver problems.

Adolescents and children weighing 50 kg or more and adults

When taking lacosamide alone:

The usual starting dose is 50 mg twice a day.

Your doctor may also prescribe a starting dose of 100 mg of lacosamide twice a day.

Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 300 mg twice a day.

When taking lacosamide with other antiepileptic medications:

The usual starting dose is 50 mg twice a day.

Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 200 mg twice a day.

If you weigh 50 kg or more, your doctor may start lacosamide treatment with a single "loading dose" of 200 mg. Then, you would start taking the continuous maintenance dose 12 hours later.

Children and adolescents weighing less than 50 kg

• In the treatment of partial onset seizures:note that lacosamide is not recommended for children under 2 years of age.
• In the treatment of primary generalized tonic-clonic seizures:note that lacosamide is not recommended for children under 4 years of age.

The dose depends on body weight. Treatment is usually started with the syrup and only changed to tablets if the patient is able to take them and obtain the correct dose with tablets of different concentrations. The doctor will prescribe the pharmaceutical form that best suits you.

If you take moreVilepsiathan you should

If you have taken more lacosamide than you should, consult your doctor immediately. Do not attempt to drive. You may experience:

• dizziness;
• feeling sick (nausea) or being sick (vomiting);
• seizures (epilepsy), heart rhythm problems such as slow, fast, or irregular pulse, coma, or low blood pressure with rapid heart rate and sweating.

In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to takeVilepsia

• If you have forgotten to take a dose within the next 6 hours of the scheduled dose, take it as soon as you remember.
• If you have forgotten to take a dose after the next 6 hours of the scheduled dose, do not take the missed dose. Instead, take lacosamide the next time you normally would.
• Do not take a double dose to make up for missed doses.

If you stop takingVilepsia

• Do not stop taking lacosamide without telling your doctor, as epilepsy may return or worsen.
• If your doctor decides to stop your treatment with lacosamide, they will give you instructions on how to gradually decrease the dose.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

Side effects on the nervous system, such as dizziness, may be greater after a single "loading dose".

Tell your doctor or pharmacist if you experience any of the following side effects:

Very common:may affect more than 1 in 10 people

• headache;
• feeling dizzy or sick (nausea);
• double vision (diplopia).

Common:may affect up to 1 in 10 people

• brief muscle or muscle group jerks (myoclonic seizures);
• difficulty coordinating movements or walking;
• problems maintaining balance, agitation (shaking), tingling (paresthesia), or muscle spasms, falling easily, and bruising;
• memory problems, thinking, or finding words, confusion;
• rapid, uncontrolled eye movements (nystagmus), blurred vision;
• feeling dizzy (vertigo), feeling drunk;
• being sick (vomiting), having a dry mouth, constipation, indigestion, excessive gas in the stomach or intestine, diarrhea;
• decreased sensitivity, difficulty articulating words, altered attention;
• noise in the ear like ringing, buzzing, or whistling;
• irritability, sleep problems, depression;
• drowsiness, fatigue, or weakness (asthenia);
• itching, rash.

Uncommon:may affect up to 1 in 100 people

• decreased heart rate, palpitations, irregular pulse, or other changes in heart activity (conduction disorder);
• exaggerated feeling of well-being, seeing and/or hearing things that are not real;
• allergic reaction to taking the medication, hives;
• Blood tests may show abnormalities in liver function tests, liver damage;
• thoughts of self-harm or suicide or attempted suicide: inform your doctor immediately;
• feeling angry or agitated;
• abnormal thoughts or loss of sense of reality;
• severe allergic reactions, which cause swelling of the face, throat, hands, feet, ankles, or lower legs;
• fainting;
• abnormal involuntary movements (dyskinesia).

Frequency not known:cannot be estimated from available data

• abnormally fast heart rhythm (ventricular tachyarrhythmia);
• sore throat, elevated temperature, and frequent infections. Blood tests may show a severe decrease in a specific class of white blood cells (agranulocytosis);
• severe skin reaction, which may include elevated temperature and other flu-like symptoms, rash on the face, generalized rash with swollen lymph nodes (lymphadenopathy). Blood tests may show elevated liver enzyme levels and an increase in a type of white blood cell (eosinophilia);
• a widespread rash with blisters and skin peeling, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome) and a more severe form that causes skin peeling over more than 30% of the body surface (toxic epidermal necrolysis):
• seizures.

Other side effects in children

Additional side effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), decreased appetite, behavioral changes, abnormal behavior, and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Vilepsia

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the box and blister pack after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Vilepsia Composition

The active ingredient is lacosamide.

• Each Vilepsia 50 mg tablet contains 50 mg of lacosamide.
• Each Vilepsia 100 mg tablet contains 100 mg of lacosamide.
• Each Vilepsia 150 mg tablet contains 150 mg of lacosamide.
• Each Vilepsia 200 mg tablet contains 200 mg of lacosamide.

The other ingredients are:

• Tablet core: microcrystalline cellulose, hydroxypropylcellulose, crospovidone, hydroxypropylcellulose (low substituted), colloidal anhydrous silica, and magnesium stearate.
• Coating: polyvinyl alcohol, titanium dioxide (E171), macrogol, talc, colorants*.

• The colorants are:

Vilepsia 50 mg tablets: red iron oxide (E172), black iron oxide (E172), and aluminum lake indigo carmine (E132).

Vilepsia 100 mg tablets: yellow iron oxide (E172) and black iron oxide (E172).

Vilepsia 150 mg tablets: yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172), and aluminum lake indigo carmine (E132).

Vilepsia 200 mg tablets: aluminum lake indigo carmine (E132).

Product Appearance and Package Contents

• Vilepsia 50 mg are film-coated, biconvex, oblong tablets, pink in color, and marked with "50" on one side.
• Vilepsia 100 mg are film-coated, biconvex, oblong tablets, dark yellow in color, and marked with "100" on one side.
• Vilepsia 150 mg are film-coated, biconvex, oblong tablets, beige in color, and marked with "150" on one side.
• Vilepsia 200 mg are film-coated, biconvex, oblong tablets, blue in color, and marked with "200" on one side.

Vilepsia 50 mg is available in packs of 14 film-coated tablets.

Vilepsia 100 mg, Vilepsia 150 mg, and Vilepsia 200 mg are available in packs of 56 film-coated tablets.

The blisters are transparent PVC/PVDC sealed with an aluminum foil.

Marketing Authorization Holder

Kern Pharma, S.L.

Venus, 72 – Pol. Ind. Colón II

08228 Terrassa – Barcelona

Spain

Manufacturer

Genepharm S.A.

18th km Marathonos Ave,

153 51 Pallini Attiki

Greece

Date of Last Revision of this Leaflet:March 2025

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.